NCT05622422

Brief Summary

The intervention aims to activate patients' inherent resources and by this, facilitate empowerment, patient activation and self-care management of their chronic disease.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

September 22, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

April 28, 2023

Status Verified

April 1, 2023

Enrollment Period

8 months

First QC Date

November 14, 2022

Last Update Submit

April 27, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • The Health Education Impact Questionnaire (heiQ)

    measures eight self-management skills in people with chronic conditions. Possible scores are on a 4 point likert scale. The scale is 1-4. higher score indicates better self-management, with the exception of the emotional wellbeing construct for which scoring is reversed.

    15 minutes

  • The Brief Illness Perception Questionnaire (B-IPQ)

    assesses the five cognitive illness representations on a five-point Likert scale. The scale is 0-10. A higher score reflects a more threatening view of the illness.

    5 minutes

  • The Patient Activation Measure (PAM)

    the measure of a person's knowledge, skills, and confidence to manage their own health and well-being on a 0-100 scale the higher score measures indicate higher patient activation.

    10 minutes

  • The European Quality of Life Questionnaire (EQ5D)

    measures a person's quality of life on a scale 0-100. The higher the score the higher the quality of life.

    10 minutes

  • The Bodyknowledging Questionnaire (BKQ)

    measures the phases of the Bodyknowledging program

    20 minutes

Study Arms (1)

Body Knowleging Program Pilot Study

EXPERIMENTAL

There will be three groups of 10 participants with a chronic disease that will receive the Body knowledging Program. The intervention aims to activate patients' inherent resources and by this, facilitate empowerment, patient activation, and self-care management of their chronic disease. The participants will include people 18 years and older that have been diagnosed with a chronic disease. This pilot study will use a pre-post design. Some of the data will be collected initially, then the intervention will be provided in seven sessions the first three face-to-face at a local community center and then the last four sessions through video conferencing that will be facilitated by three researchers. Data collection will take place at the first session and then again at the seventh session. The participants will be invited back in week nine to attend a video conference focus group to obtain qualitative data. Both qualitative and quantitative data will be analyzed.

Behavioral: EMPOWER-BKP

Interventions

EMPOWER-BKPBEHAVIORAL

The intervention aims to activate patients' inherent resources and by this, facilitate empowerment, patient activation, and self-care management of their chronic disease. The participants will include people 18 years and older that have been diagnosed with a chronic disease. This pilot study will use a pre-post design. Some of the data will be collected initially at the first session and then again at the seventh session. The intervention will be provided in seven sessions the first three will be face-to-face at a community center and then the last four sessions will be through video conferencing and will be facilitated by three researchers. The participants will be invited to a focus group interview in week nine in order to collect quantitative data. Once the sessions are finished both qualitative and quantitative data will be collected and then analyzed.

Body Knowleging Program Pilot Study

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Undergoing treatment for chronic illness
  • Cognitive capacity to participate in group formats
  • Able to answer questions from questionnaires
  • Able to read and speak English.
  • Score greater than 18 on the MoCA cognitive test

You may not qualify if:

  • Major reduction in cognitive capacity (i.e. major strokes, dementia, or other related conditions).
  • Serious mental illness that impacts the ability to give consent or limits effective participation within a group discussion as assessed by the PI and RA in consultation following routine study protocols used in the study setting (patients may suffer from mild cognitive impairment but must be able to understand and complete questionnaires and engage in intervention groups).
  • Patients in palliative phases of cancer.
  • Patients in an acute medical crisis or in need of intensive care. -Patients who attend similar interventions in the same period or within the past 3 months. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Chronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Natalie A Stepanian, Ph.D.

    Pace University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Natalie A Stepanian, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: mixed method
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 14, 2022

First Posted

November 18, 2022

Study Start

September 22, 2023

Primary Completion

May 31, 2024

Study Completion

May 31, 2024

Last Updated

April 28, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

The individual participant data will not be shared with other researchers.